Yong Song

12PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Space sciences not elsewhere classifiedNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 22, 2024
First-line chemoimmunotherapy for patients with small-cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis.

Yu Li, Yuxin Jiang, Luyun Pan

|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Gen Lin, Zhijie Wang, Qian Chu

|Nov 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Dingzhi Huang, Gen Lin, Qian Chu

|Sep 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Xingxiang Pu, Chunwei Xu, Qian Wang

|Jul 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Qian Wang, Chunwei Xu, Wenxian Wang

|Apr 02, 2023
Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched study.

Jingyuan Xie, Mo Chen, Hedong Han

Pageof 2

Frequent Collaborators

7 joint publications

Yong Song

6 joint publications

Chunwei Xu

5 joint publications

Wenxian Wang

4 joint publications

Chengzhi Zhou